Requesting that the FDA declare that Potassium Chloride Extended release for Liquid Suspension, 8 mEq and 10 mEq, are suitable for submission as an ANDA
🏛 Food and Drug Administration (FDA)FDA-2020-P-2181
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.